SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (14675)9/16/2000 10:00:58 PM
From: Bluegreen  Read Replies (2) | Respond to of 17367
 
You stated>>>>>>>>Anyway, the FACT is there is not a single surrogate point proven clearly to get subpartE designation approval.<<<<<<<<<
SHAME on you! Not fact. That is YOUR opinion.



To: Cacaito who wrote (14675)9/16/2000 10:07:03 PM
From: Robert K.  Read Replies (1) | Respond to of 17367
 
Lets get one thing straight Cacaito. You claim p0.05 is proof. That is total manure and you know it. That is a datapoint where the FDA has deemed 95% confidence is proof.
Since when is 95% of anything proof. So 94% confidence is a total failure according to fda standards (and yours).
What bull. Its merely a unified reference point for validity. So bpi missed the 95% standard, kids are gonna die for it.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News